Clinical outcomes in COVID‐19 patients treated with tocilizumab: An individual patient data systematic review
Author:
Affiliation:
1. Reno School of Medicine University of Nevada Reno Nevada
2. U.S. Department of Veterans Affairs VA Sierra Nevada Health Care Systems Reno Nevada
Publisher
Wiley
Subject
Infectious Diseases,Virology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26038
Reference26 articles.
1. WHO.WHO Director‐General's opening remarks at the media briefing on COVID‐19—11 March2020.https://www.who.int/dg/speeches/detail/who‐director‐general‐s‐opening‐remarks‐at‐the‐media‐briefing‐on‐covid‐19‐‐‐11‐march‐2020
2. COVID-19: consider cytokine storm syndromes and immunosuppression
3. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
4. Pathological findings of COVID-19 associated with acute respiratory distress syndrome
5. CoomesEA HaghbayanH.Interleukin‐6 in COVID‐19: a systematic review and meta‐analysis.medRxiv.2020.https://doi.org/10.1101/2020.03.30.20048058
Cited by 87 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Unlocking the Potential of Therapy-Induced Cytokine Responses: Illuminating New Pathways in Cancer Precision Medicine;Current Oncology;2024-02-23
2. An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic;International Journal of Molecular Sciences;2023-12-26
3. Overlapping research efforts in a global pandemic: a rapid systematic review of COVID-19-related individual participant data meta-analyses;BMC Health Services Research;2023-07-06
4. COVID-19 individual participant data meta-analyses. Can there be too many? Results from a rapid systematic review.;2023-01-03
5. A narrative review on tofacitinib: The properties, function, and usefulness to treat coronavirus disease 2019;International Journal of Critical Illness and Injury Science;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3